Nkx-3.2 inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of Nkx-3.2, a protein encoded by the NKX3-2 gene. Nkx-3.2, also known as NK3 homeobox 2, is a member of the NK family of homeobox genes, which play crucial roles in regulating developmental processes. This transcription factor is involved in the regulation of chondrogenesis, the process by which cartilage is formed from condensed mesenchyme tissue, and is essential for the proper development of the skeletal system. Nkx-3.2 functions by binding to specific DNA sequences and regulating the transcription of target genes that are involved in the differentiation and proliferation of chondrocytes, the cells responsible for cartilage formation.
Structurally, Nkx-3.2 inhibitors can vary widely, including small molecules, peptides, or larger biomolecules that are engineered to interact specifically with the DNA-binding domain or other critical regions of the Nkx-3.2 protein. These inhibitors typically function by preventing Nkx-3.2 from binding to its target DNA sequences, thereby blocking its ability to regulate gene transcription. By inhibiting Nkx-3.2, these compounds can disrupt the transcriptional networks controlled by this factor, leading to changes in the expression of genes involved in chondrocyte differentiation and cartilage formation. The study of Nkx-3.2 inhibitors is crucial for understanding the regulatory mechanisms underlying Nkx-3.2's role in gene expression and its impact on developmental processes. Research into these inhibitors provides valuable insights into the broader implications of transcription factor regulation in cellular biology, highlighting the importance of precise control of gene expression in maintaining cellular identity and function. By exploring the effects of Nkx-3.2 inhibition, scientists can gain a deeper understanding of the intricate networks of gene regulation and the role of transcription factors in orchestrating the complex processes of development and differentiation.
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | ¥1061.00 ¥3227.00 | 27 | |
IWP-2通过阻断Wnt和β-catenin通路抑制Wnt信号传导。NKX(NK homeobox)参与受Wnt信号传导影响的胰腺发育,IWP-2抑制该通路可间接抑制NKX(NK homeobox)。 | ||||||
GANT61 | 500579-04-4 | sc-202630 sc-202630A sc-202630B | 1 mg 5 mg 10 mg | ¥711.00 ¥1444.00 ¥2256.00 | 6 | |
GANT-61通过阻断GLI转录因子来抑制Hedgehog(Hh)信号传导。NKX(NK homeobox)是受Hh信号传导影响的神经管模式的一部分,GANT-61可以通过干扰Hh信号传导活性来间接抑制NKX(NK homeobox)。 | ||||||
SIS3 hydrochloride | 521984-48-5 | sc-253565 | 5 mg | ¥3768.00 | 2 | |
SIS3通过阻断Smad3的磷酸化来抑制TGF-β/Smad3信号传导。NKX(NK homeobox)与受TGF-β信号传导影响的胰腺发育有关,SIS3可通过调节TGF-β/Smad3通路间接抑制NKX(NK homeobox)。 | ||||||
DMH-1 | 1206711-16-1 | sc-361171 sc-361171B sc-361171A sc-361171C | 10 mg 25 mg 50 mg 100 mg | ¥2358.00 ¥3520.00 ¥6995.00 ¥11575.00 | 2 | |
DMH1通过靶向BMP I型受体来抑制BMP信号传导。DMH1抑制BMP信号传导,可间接抑制NKX(NK homeobox),因为NKX(NK homeobox)与受BMP信号传导影响的神经发育有关。 | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | ¥1038.00 ¥2302.00 | 19 | |
环磷酰胺通过阻断Smoothened(SMO)抑制Hedgehog(Hh)信号传导。NKX(NK homeobox)是受Hh信号传导影响的神经管模式的一部分,环磷酰胺可通过破坏Hh通路活性间接抑制NKX(NK homeobox)。 | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | ¥903.00 ¥2392.00 ¥4603.00 | 48 | |
SB431542通过阻断I型受体来抑制TGF-β/Activin/Nodal信号传导。NKX(NK homeobox)受TGF-β信号传导影响,参与胰腺发育,SB431542可通过干扰TGF-β/Activin/Nodal通路来间接抑制NKX(NK homeobox)。 | ||||||
IWR-1-endo | 1127442-82-3 | sc-295215 sc-295215A | 5 mg 10 mg | ¥925.00 ¥1489.00 | 19 | |
IWR-1-endo通过稳定Axin来抑制Wnt信号传导。NKX(NK homeobox)受Wnt信号传导影响参与胰腺发育,IWR-1-endo可通过促进β-catenin降解和调节Wnt信号传导活性来间接抑制NKX(NK homeobox)。 | ||||||
Dorsomorphin dihydrochloride | 1219168-18-9 | sc-361173 sc-361173A | 10 mg 50 mg | ¥2053.00 ¥8304.00 | 28 | |
Dorsomorphin通过靶向BMP I型受体抑制BMP信号传导。由于NKX(NK homeobox)与受BMP信号传导影响的神经发育有关,因此Dorsomorphin对BMP的抑制作用可间接抑制NKX(NK homeobox)。 | ||||||
LY 364947 | 396129-53-6 | sc-203122 sc-203122A | 5 mg 10 mg | ¥1185.00 ¥1726.00 | 4 | |
LY364947通过阻断I型受体来抑制TGF-β/Smad2/3信号传导。NKX(NK homeobox)与受TGF-β信号传导影响的胰腺发育有关,LY364947可通过干扰TGF-β/Smad2/3通路间接抑制NKX(NK homeobox)。 |